These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

699 related articles for article (PubMed ID: 25409146)

  • 1. MicroRNA silencing for cancer therapy targeted to the tumour microenvironment.
    Cheng CJ; Bahal R; Babar IA; Pincus Z; Barrera F; Liu C; Svoronos A; Braddock DT; Glazer PM; Engelman DM; Saltzman WM; Slack FJ
    Nature; 2015 Feb; 518(7537):107-10. PubMed ID: 25409146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer: New delivery platform targets antimirs to tumours.
    Flemming A
    Nat Rev Drug Discov; 2014 Dec; 13(12):888. PubMed ID: 25435213
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.
    Dhuri K; Gaddam RR; Vikram A; Slack FJ; Bahal R
    Cancer Res; 2021 Nov; 81(22):5613-5624. PubMed ID: 34548334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma.
    Kunz M; Brandl M; Bhattacharya A; Nobereit-Siegel L; Ewe A; Weirauch U; Hering D; Reinert A; Kalwa H; Guzman J; Weigelt K; Wach S; Taubert H; Aigner A
    J Nanobiotechnology; 2020 Nov; 18(1):173. PubMed ID: 33228711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
    Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
    Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-targeted Delivery of Anti-microRNA for Cancer Therapy: pHLIP is Key.
    Wagner E
    Angew Chem Int Ed Engl; 2015 May; 54(20):5824-6. PubMed ID: 25892205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines.
    Dhuri K; Pradeep SP; Shi J; Anastasiadou E; Slack FJ; Gupta A; Zhong XB; Bahal R
    Pharm Res; 2022 Nov; 39(11):2709-2720. PubMed ID: 36071352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
    Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
    Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Peptide Nucleic Acids: Principles, Limitations, and Opportunities.
    Quijano E; Bahal R; Ricciardi A; Saltzman WM; Glazer PM
    Yale J Biol Med; 2017 Dec; 90(4):583-598. PubMed ID: 29259523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-assembled peptide nucleic acid-microRNA nanocomplex for dual modulation of cancer-related microRNAs.
    Wang X; Xiao X; Zhang B; Li J; Zhang Y
    Chem Commun (Camb); 2019 Feb; 55(14):2106-2109. PubMed ID: 30698603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid Nanoparticles Composed of Quaternary Amine-Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer.
    Yung BC; Li J; Zhang M; Cheng X; Li H; Yung EM; Kang C; Cosby LE; Liu Y; Teng L; Lee RJ
    Mol Pharm; 2016 Feb; 13(2):653-62. PubMed ID: 26741162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma.
    Babar IA; Cheng CJ; Booth CJ; Liang X; Weidhaas JB; Saltzman WM; Slack FJ
    Proc Natl Acad Sci U S A; 2012 Jun; 109(26):E1695-704. PubMed ID: 22685206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment.
    Raue R; Frank AC; Syed SN; Brüne B
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duality of oncomiR addiction in the maintenance and treatment of cancer.
    Cheng CJ; Slack FJ
    Cancer J; 2012; 18(3):232-7. PubMed ID: 22647359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of oncomirs in the pathogenesis and treatment of breast cancer.
    Hemmatzadeh M; Mohammadi H; Jadidi-Niaragh F; Asghari F; Yousefi M
    Biomed Pharmacother; 2016 Mar; 78():129-139. PubMed ID: 26898434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice.
    Lucas T; Schäfer F; Müller P; Eming SA; Heckel A; Dimmeler S
    Nat Commun; 2017 May; 8():15162. PubMed ID: 28462946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.
    Kheirolomoom A; Kim CW; Seo JW; Kumar S; Son DJ; Gagnon MK; Ingham ES; Ferrara KW; Jo H
    ACS Nano; 2015 Sep; 9(9):8885-97. PubMed ID: 26308181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension.
    McLendon JM; Joshi SR; Sparks J; Matar M; Fewell JG; Abe K; Oka M; McMurtry IF; Gerthoffer WT
    J Control Release; 2015 Jul; 210():67-75. PubMed ID: 25979327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound and Microbubble-targeted Delivery of a microRNA Inhibitor to the Heart Suppresses Cardiac Hypertrophy and Preserves Cardiac Function.
    Kopechek JA; McTiernan CF; Chen X; Zhu J; Mburu M; Feroze R; Whitehurst DA; Lavery L; Cyriac J; Villanueva FS
    Theranostics; 2019; 9(23):7088-7098. PubMed ID: 31660088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.